Accendra Health Statistics
Total Valuation
Accendra Health has a market cap or net worth of $155.93 million. The enterprise value is $2.04 billion.
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Accendra Health has 76.44 million shares outstanding. The number of shares has increased by 0.20% in one year.
| Current Share Class | 76.44M |
| Shares Outstanding | 76.44M |
| Shares Change (YoY) | +0.20% |
| Shares Change (QoQ) | -0.76% |
| Owned by Insiders (%) | 4.08% |
| Owned by Institutions (%) | 76.51% |
| Float | 60.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 3.41 |
| PS Ratio | 0.06 |
| Forward PS | 0.06 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.74 |
| EV / EBITDA | 5.65 |
| EV / EBIT | 13.93 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.58
| Current Ratio | 0.58 |
| Quick Ratio | 0.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.87 |
| Debt / FCF | n/a |
| Interest Coverage | 1.28 |
Financial Efficiency
Return on equity (ROE) is -163.79% and return on invested capital (ROIC) is 9.14%.
| Return on Equity (ROE) | -163.79% |
| Return on Assets (ROA) | 2.57% |
| Return on Invested Capital (ROIC) | 9.14% |
| Return on Capital Employed (ROCE) | 9.72% |
| Weighted Average Cost of Capital (WACC) | 4.64% |
| Revenue Per Employee | $424,928 |
| Profits Per Employee | -$169,330 |
| Employee Count | 6,500 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 20.74 |
Taxes
In the past 12 months, Accendra Health has paid $729,000 in taxes.
| Income Tax | 729,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.33% in the last 52 weeks. The beta is 1.29, so Accendra Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -77.33% |
| 50-Day Moving Average | 2.34 |
| 200-Day Moving Average | 4.49 |
| Relative Strength Index (RSI) | 35.45 |
| Average Volume (20 Days) | 859,859 |
Short Selling Information
The latest short interest is 8.16 million, so 10.67% of the outstanding shares have been sold short.
| Short Interest | 8.16M |
| Short Previous Month | 8.82M |
| Short % of Shares Out | 10.67% |
| Short % of Float | 13.56% |
| Short Ratio (days to cover) | 7.77 |
Income Statement
In the last 12 months, Accendra Health had revenue of $2.76 billion and -$1.10 billion in losses. Loss per share was -$14.32.
| Revenue | 2.76B |
| Gross Profit | 1.29B |
| Operating Income | 146.21M |
| Pretax Income | -101.95M |
| Net Income | -1.10B |
| EBITDA | 360.74M |
| EBIT | 146.21M |
| Loss Per Share | -$14.32 |
Full Income StatementBalance Sheet
The company has $281.99 million in cash and $2.16 billion in debt, with a net cash position of -$1.88 billion or -$24.61 per share.
| Cash & Cash Equivalents | 281.99M |
| Total Debt | 2.16B |
| Net Cash | -1.88B |
| Net Cash Per Share | -$24.61 |
| Equity (Book Value) | -460.98M |
| Book Value Per Share | -6.03 |
| Working Capital | -399.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$101.79 million and capital expenditures -$190.96 million, giving a free cash flow of -$292.75 million.
| Operating Cash Flow | -101.79M |
| Capital Expenditures | -190.96M |
| Depreciation & Amortization | 214.52M |
| Net Borrowing | 203.50M |
| Free Cash Flow | -292.75M |
| FCF Per Share | -$3.83 |
Full Cash Flow StatementMargins
Gross margin is 46.68%, with operating and profit margins of 5.29% and -39.85%.
| Gross Margin | 46.68% |
| Operating Margin | 5.29% |
| Pretax Margin | -3.69% |
| Profit Margin | -39.85% |
| EBITDA Margin | 13.06% |
| EBIT Margin | 5.29% |
| FCF Margin | n/a |
Dividends & Yields
Accendra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.20% |
| Shareholder Yield | -0.20% |
| Earnings Yield | -705.85% |
| FCF Yield | -187.74% |
Analyst Forecast
The average price target for Accendra Health is $3.38, which is 65.69% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.38 |
| Price Target Difference | 65.69% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 1, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Apr 1, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Accendra Health has an Altman Z-Score of 0.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.62 |
| Piotroski F-Score | 3 |
